Sistemic | GenomeWeb

Sistemic

The firms will use miRNA-based cell characterization workflows and technologies to develop panels for human MSC products and cell banks.

NEW YORK (GenomeWeb News) – Sistemic today announced an agreement with NHS Scotland to develop biomarkers for the early detection of diabetic retinopathy and infective keratitis.
Financial and other terms of the deal were not disclosed.

Sistemic, a microRNA profiling firm, said this week that it has signed a deal under which NeoStem subsidiary Progenitor Cell Therapy will evaluate its stem cell-characterization technology.

NEW YORK (GenomeWeb News) – EMD Millipore today said it is jointly developing a microRNA biomarker-based monitoring methodology with Sistemic for the consistent growth of stem cells in EMD Millipore's Mobius CellReady platform.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Sistemic, an miRNA-based products developer, said today that it has received an undisclosed amount of funding from the economic development entity Scottish Enterprise.

New Releases

Premium

Sistemic's Companion Biomarker Program

Roslin Cells will use Sistemic's SistemQC service, which applies miRNA profiling to monitor stem cell identity, safety, and differentiation staging.

The firms announced a memorandum of understanding to to promote technologies to standardize the manufacture of stem cells for use in cell therapy and drug development screening.

Sistemic will provide its SistemRNA suite of drug development tools in order to accelerate Redx's preclinical development pipeline of more than 250 new drug candidates.

Products & Services

Premium

Norgen Biotek, Sistemic

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.